Mercury Biopharmaceutical Corporation (TPEX:6932)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.80
-0.30 (-2.48%)
Apr 9, 2025, 2:59 PM CST

Mercury Biopharmaceutical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
5,1047,7784,006---
Market Cap Growth
-38.81%94.15%----
Enterprise Value
4,9207,4653,937---
Last Close Price
12.1018.709.87---
PS Ratio
1157.467530.001494.92---
PB Ratio
17.8020.0322.22---
P/TBV Ratio
17.8620.1722.28---
EV/Sales Ratio
1107.597226.331469.06---
Debt / Equity Ratio
0.130.110.240.19-1.43150.00
Asset Turnover
0.010.000.02---
Quick Ratio
20.0741.3319.791.500.280.98
Current Ratio
20.5742.2120.152.300.321.01
Return on Equity (ROE)
-11.79%-15.41%-32.76%-103.62%--
Return on Assets (ROA)
-6.98%-8.55%-15.87%-49.15%-103.35%-
Return on Capital (ROIC)
-7.12%-8.73%-16.35%-52.74%-108.47%-
Earnings Yield
-0.99%-0.56%-0.78%---
FCF Yield
-0.88%-0.71%-2.35%---
Buyback Yield / Dilution
-3.20%-9.00%-36.09%-165.94%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.